MedPath

Effect of Instrument-Assisted Soft Tissue Mobilization on Gastrocnemius Stiffness and Ankle Range of Motion

Not Applicable
Recruiting
Conditions
Muscle Stiffness
Registration Number
NCT06934694
Lead Sponsor
University of Primorska
Brief Summary

This study will examine whether a technique called instrument-assisted soft tissue mobilization (IASTM) can reduce stiffness in the calf muscle (gastrocnemius) and improve ankle mobility. Muscle stiffness will be measured using a specialized ultrasound method called shear-wave elastography, while ankle range of motion will be assessed using the weight-bearing lunge test. Healthy volunteers will participate in this study, and measurements will be taken before and after a single IASTM treatment. The aim is to determine if this manual therapy technique can produce immediate changes in muscle properties and joint flexibility.

Detailed Description

This interventional study aims to evaluate the acute effects of instrument-assisted soft tissue mobilization (IASTM) on the stiffness of the gastrocnemius muscle and ankle dorsiflexion range of motion. Muscle stiffness will be quantified using shear-wave elastography (SWE), a non-invasive ultrasound technique that measures tissue mechanical properties in real time. Ankle dorsiflexion range of motion will be assessed using the weight-bearing lunge test with the knee extended, a reliable functional measure of ankle mobility.

Participants will undergo baseline measurements followed by a standardized IASTM intervention targeting the gastrocnemius muscle. Post-treatment assessments will be conducted immediately afterward to capture acute changes. The study is designed to improve understanding of how IASTM influences muscle mechanical properties and functional joint mobility. Findings may have implications for the clinical use of IASTM in both rehabilitation and performance contexts.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
38
Inclusion Criteria
  • Age between 18 and 45 years
  • Healthy individuals without current lower limb injury
  • No history of surgery to the ankle, knee, or calf
  • Able to perform the weight-bearing lunge test without assistance
  • Willing to refrain from intense lower-limb exercise 24 hours before testing
Exclusion Criteria
  • Current or recent (past 3 months) lower limb musculoskeletal pain or injury
  • Known neuromuscular or vascular disorders affecting the lower extremity
  • Use of medications affecting muscle tone or flexibility within 48 hours prior to testing
  • Previous adverse reactions to manual therapy or IASTM
  • Skin lesions, bruising, or conditions over the gastrocnemius that contraindicate IASTM
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Muscle stiffnessBaseline and Immediately Post-Intervention

Stiffness of the gastrocnemius muscle will be measured using shear-wave elastography (SWE), a non-invasive ultrasound technique that quantifies the shear modulus of soft tissue. Measurements will be performed with the participant in a prone position, with the ankle in a standardized neutral position, to ensure consistency. The shear modulus (in kilopascals) will be used as the primary metric of muscle stiffness.

Time Frame:

Secondary Outcome Measures
NameTimeMethod
Ankle Dorsiflexion Range of MotionBaseline and Immediately Post-Intervention

Ankle dorsiflexion range of motion will be assessed using the weight-bearing lunge test with the knee extended. The distance from the great toe to the wall will be recorded at the point where the heel remains in contact with the floor while the knee touches the wall. This test is a reliable and functional assessment of gastrocnemius-related ankle flexibility.

Trial Locations

Locations (1)

University of Primorska, Faculty of Health Sciences, Izola

🇸🇮

Izola, Slovenia

University of Primorska, Faculty of Health Sciences, Izola
🇸🇮Izola, Slovenia
Žiga Kozinc, PhD
Contact
040161503
ziga.kozinc@fvz.upr.si

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.